无创影像在混合型肝细胞癌-胆管癌诊断中的应用
本文综述混合型肝细胞癌-胆管癌(cHCC-CC)的流行病学、病理、分子生物学和血清学特征,重点回顾超声等无创影像在该病诊断和预后评估中的应用,并指出影像研究的不足与展望。
要点
- cHCC-CC是一种罕见的双表型原发性肝癌,术前无创影像准确识别具有重要价值。
- 超声等无创影像可用于cHCC-CC的诊断与预后评估。
- cHCC-CC缺乏明确的人口学和临床特征,影像诊断存在挑战。
核心结论
- cHCC-CC预后较差且侵袭性较强,术前清晰识别和准确的无创影像诊断分析具有重要价值。
研究设计与样本
- 综述类文章,检索范围与纳入文献数原文未报告。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare type of primary liver cancer. It is a complex "biphenotypic" tumor type consisting of bipotential hepatic progenitor cells that can differentiate into cholangiocytes subtype and hepatocytes subtype. The prognosis of patients with cHCC-CC is quite poor with its specific and more aggressive nature. Furthermore, there are no definite demographic or clinical features of cHCC-CC, thus a clear preoperative identification and accurate non-invasive imaging diagnostic analysis of cHCC-CC are of great value. In this review, we first summarized the epidemiological features, pathological findings, molecular biological information and serological indicators of cHCC-CC disease. Then we reviewed the important applications of non-invasive imaging modalities-particularly ultrasound (US)-in cHCC-CC, covering both diagnostic and prognostic assessment of patients with cHCC-CC. Finally, we presented the shortcomings and potential outlooks for imaging studies in cHCC-CC.
引用
- Shen, Yue, Xu, et al. Non-invasive imaging in the diagnosis of combined hepatocellular carcinoma and cholangiocarcinoma. Abdom Radiol (NY). 2023. PMID: 36961531. doi:10.1007/s00261-023-03879-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。